🩸 A New Hope for Vaccine-Injured Patients

🩸 A New Hope for Vaccine-Injured Patients
People are traveling to Japan for a promising treatment the FDA will not approve in the United States because of regulations.
DFPP (Double Filtration Plasmapheresis) is an established blood purification technique widely used in Japan and parts of Asia for autoimmune diseases, neurological conditions, and metabolic disorders.
It works like a high-tech “blood laundry” in a closed circuit: blood is drawn, the plasma is separated and passed through two specialized filters to remove harmful molecules (autoantibodies, cytokines, immune complexes, and potentially spike-related amyloids), then the cleaned blood is returned to the patient — all without needing donor plasma.
Often combined with stem cell-derived growth factor infusions, this protocol is giving real relief to suffering for years and helping to remove mRNA spike proteins from those Covid vaccine injured.
Edogawa Hospital (Tokyo) – Primary site for the specialized “Edogawa-McCairn Protocol” (DFPP + SCGF infusions) for vaccine injury/long COVID
This is the hospital repeatedly featured in recent patient testimonials for exactly the treatment you described. It is a general hospital (with a focus on areas like cancer) collaborating with neuroscientist Dr. Kevin McCairn PhD and Synaptek Labs on testing and this protocol.
Protocol details: DFPP sessions (often 2–4, via jugular catheter for efficiency) to filter out spike-related amyloids, microclots, cytokines, etc., combined with daily IV stem cell-derived growth factor infusions for repair/support. Some patients report rapid improvements in energy, mobility, neurological symptoms, and “resetting” after treatment.
Patient examples (anecdotal): “Robert” (described as the ~12th patient) reported going from severe disability to hiking with his wife. Other Americans (e.g., RN Lyndsey, Ken Evans as ~14th patient, Tamara Fishman) have shared dramatic recoveries in videos/interviews. Dr. Mary Talley Bowden has referred at least two patients and is fundraising to replicate it in the US.
Pre-treatment: Strongly recommended—send dried blood samples to Synaptek Labs for amyloid/fibril, cytokine, and spike-related testing (protocol on their site). This helps determine candidacy.
Contact/Access: Not heavily advertised publicly as a “vaccine injury clinic.” Reach out via Synaptek Labs (synapteklabs.com; contact form or kevin@synaptek.jp). Dr. McCairn’s network, Dr. Bowden’s referrals, or the hospital’s international patient department (Edogawa Hospital website: search bnct-edogawa.com or similar). Patients coordinate through this ecosystem.
Cost estimate: ~$5,000 USD per DFPP session; full protocol (multiple sessions + SCGF + stay/support) often cited as $20,000–$40,000+ USD total for 2 weeks (varies; self-pay). Travel/lodging extra.
Location: Edogawa-ku, Tokyo.
Kilde: Telegram "qanonplus"